Ginkgo Bioworks Company Insiders

Ginkgo Bioworks Management Team Effectiveness

The company has Return on Asset of (0.1699) % which means that on every $100 spent on assets, it lost $0.1699. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5776) %, meaning that it generated no profit with money invested by stockholders. Ginkgo Bioworks' management efficiency ratios could be used to measure how well Ginkgo Bioworks manages its routine affairs as well as how well it operates its assets and liabilities. As of July 24, 2025, Return On Tangible Assets is expected to decline to -0.44. In addition to that, Return On Capital Employed is expected to decline to -0.46. At present, Ginkgo Bioworks' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 44.8 M, whereas Net Tangible Assets are forecasted to decline to about 1.1 B. As of July 24, 2025, Common Stock Shares Outstanding is expected to decline to about 49.3 M. In addition to that, Net Loss is expected to decline to about (574.4 M)

Ginkgo Bioworks Workforce Comparison

Ginkgo Bioworks Profit Margins

The company has Net Profit Margin of (1.99) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (1.82) %, which entails that for every $100 of revenue, it lost $1.82.

Ginkgo Bioworks Insider Trading History

Ginkgo Bioworks Notable Stakeholders

The success or failure of an entity such as Ginkgo Bioworks Holdings often depends on how effective the management is. Ginkgo Bioworks management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ginkgo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ginkgo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Ginkgo Bioworks' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ginkgo Bioworks' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ginkgo Bioworks' management manipulating its earnings.

When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.